APS03118
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APS03118, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions [Phase 1]